CDKN2B-AS1 and chronic kidney disease: Correspondingly, our group reported that the ANRIL SNP rs10757278 (GG) doubled the risk of major adverse cardiovascular events (MACEs) in patients with chronic kidney disease (CKD) who were on hemodialysis, via an unknown mechanism [134].